Skip to main content

Table 3 Hazard ratios for the primary outcome at different time intervals

From: Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease

 

GA-CV

GA-VIM

GA-ARV

No. of participants

436

436

436

< 1 year

 No. of cases

13

13

13

 Person-years

298

298

298

 Age-adjusted HRs

0.97 (0.90–1.05)

0.85 (0.40–1.78)

1.01 (0.83–1.24)

 Multivariable adjusted HRs

0.99 (0.91–1.07)

0.97 (0.44–2.12)

1.05 (0.85–1.30)

< 2 years

 No. of cases

44

44

44

 Person-years

543

543

543

 Age-adjusted HRs

1.02 (0.98–1.06)

1.21 (0.84–1.74)

1.09 (0.98–1.20)

 Multivariable adjusted HRs

1.02 (0.98–1.06)

1.18 (0.79–1.75)

1.08 (0.97–1.21)

< 3 years

 No. of cases

73

73

73

 Person-years

725

725

725

 Age-adjusted HRs

1.03 (0.99–1.06)

1.33 (1.01–1.77)

1.10 (1.01–1.19)

 Multivariable adjusted HRs

1.02 (0.99–1.05)

1.22 (0.90–1.66)

1.06 (0.97–1.16)

< 4 years

 No. of cases

88

88

88

 Person-years

852

852

852

 Age-adjusted HRs

1.03 (1.01–1.06)

1.33 (1.05–1.75)

1.10 (1.03–1.18)

 Multivariable adjusted HRs

1.03 (1.01–1.06)

1.30 (0.99–1.70)

1.07 (0.99–1.15)

< 5 years

 No. of cases

95

95

95

 Person-years

929

929

929

 Age-adjusted HRs

1.03 (1.01–1.05)

1.36 (1.07–1.73)

1.10 (1.03–1.18)

 Multivariable adjusted HRs

1.03 (1.01–1.05)

1.27(0.98–1.64)

1.07 (0.99–1.15)

< 6 years

 No. of cases

106

106

106

 Person-years

976

976

976

 Age-adjusted HRs

1.03 (1.01–1.06)

1.39 (1.11–1.75)

1.10 (1.03–1.18)

 Multivariable adjusted HRs

1.03 (1.01–1.05)

1.29 (1.01–1.66)

1.06 (0.99–1.14)

≥ 6 years

 No. of cases

112

112

112

 Person-years

1006

1006

1006

 Age-adjusted HRs

1.03 (1.01–1.06)

1.40 (1.12–1.76)

1.10 (1.03–1.18)

 Multivariable adjusted HRs

1.03 (1.01–1.06)

1.32 (1.03–1.69)

1.07 (1.01–1.15)

  1. Multivariable adjustments included diabetes duration, smoking status, eGFR, HDL, aspirin, and mean HbA1c